干细胞治疗白癜风的基础及临床研究进展

doi:10.35541/cjd.20240127

Abstract

Abstract: 【Abstract】 Stem cells are a kind of cells with the ability of self-renewal and differentiation, which can differentiate into melanocytes to fill the areas of pigment loss in damaged skin, fight against the apoptosis of melanocytes caused by autoimmunity and oxidative stress damage, and improve repigmentation rates in combination with traditional therapies. Studies have shown significant efficacy of stem cell therapy in the repigmentation of vitiligo. This review summarizes the latest advances in the basic and clinical research on the application of stem cells in the treatment of vitiligo.

Key words: Vitiligo, Stem cells, Melanocytes, Autoimmunity, Oxidative stress

CLC Number:

Zhang Yude, Wang Hongjuan, Kang Xiaojing. Stem cell therapy for vitiligo: advances in basic and clinical research[J]. Chinese Journal of Dermatology,2024,e20240127. doi:10.35541/cjd.20240127

References ［31］

［1］	Liu H, Wang Y, Le Q, et al. The IFN⁃γ⁃CXCL9/CXCL10⁃CXCR3 axis in vitiligo: pathological mechanism and treatment［J］. Eur J Immunol, 2024,54（4）:e2250281. doi: 10.1002/eji. 202250281.
［2］	Frisoli ML, Essien K, Harris JE. Vitiligo: mechanisms of pathogenesis and treatment［J］. Annu Rev Immunol, 2020,38:621⁃648. doi: 10.1146/annurev⁃immunol⁃100919⁃023531.
［3］	Arjmand B, Bahrami⁃Vahdat E, Alavi⁃Moghadam S, et al. Human⁃induced pluripotent stem cell‒derived keratinocytes, as therapeutic option in vitiligo［J］. Methods Mol Biol, 2024:185⁃202. doi: 10.1007/7651_2023_510.
［4］	Esquivel D, Mishra R, Srivastava A. Stem cell therapy offers a possible safe and promising alternative approach for treating vitiligo: a review［J］. Curr Pharm Des, 2020,26（37）:4815⁃4821. doi: 10.2174/1381612826666200730221446.
［5］	Wang Y, He Z, Luo B, et al. Human mesenchymal stem cell⁃derived exosomes promote the proliferation and melanogenesis of primary melanocytes by attenuating the H2O2⁃related cytotoxicity in vitro［J］. Clin Cosmet Investig Dermatol, 2024,17:683⁃695. doi: 10.2147/CCID.S446676.
［6］	Kobori C, Takagi R, Yokomizo R, et al. Functional and long⁃lived melanocytes from human pluripotent stem cells with transient ectopic expression of JMJD3［J］. Stem Cell Res Ther, 2023,14（1）:242. doi: 10.1186/s13287⁃023⁃03479⁃1.
［7］	Liu LP, Li YM, Guo NN, et al. Therapeutic potential of patient iPSC⁃derived iMelanocytes in autologous transplantation［J］. Cell Rep, 2019,27（2）:455⁃466.e5. doi: 10.1016/j.celrep.2019. 03.046.
［8］	Saidani M, Darle A, Jarrige M, et al. Generating functional and highly proliferative melanocytes derived from human pluripotent stem cells: a promising tool for biotherapeutic approaches to treat skin pigmentation disorders［J］. Int J Mol Sci, 2023,24（7）:6398. doi: 10.3390/ijms24076398.
［9］	Bellei B, Migliano E, Picardo M. Therapeutic potential of adipose tissue⁃derivatives in modern dermatology［J］. Exp Dermatol, 2022,31（12）:1837⁃1852. doi: 10.1111/exd.14532.
［10］	Zavala G, Sandoval C, Meza D, et al. Differentiation of adipose⁃derived stem cells to functional CD105neg CD73low melanocyte precursors guided by defined culture condition［J］. Stem Cell Res Ther, 2019,10（1）:249. doi: 10.1186/s13287⁃019⁃1364⁃0.
［11］	Mei X, Sun Y, Wu Z, et al. In vitro⁃induced differentiation of bone marrow mesenchymal stem cells into melanocytes［J］. Cell Biol Int, 2015,39（7）:824⁃833. doi: 10.1002/cbin.10455.
［12］	Xie Y, Xu Z, Shi W, et al. Biological function and application of melanocytes induced and transformed by mouse bone marrow mesenchymal stem cells［J］. Regen Ther, 2022,21:148⁃156. doi: 10.1016/j.reth.2022.06.007.
［13］	Yoon JH, Kim HJ, Kim JH, et al. BMP4⁃induced differentiation of human hair follicle neural crest stem cells into precursor melanocytes from hair follicle bulge［J］. Ann Dermatol, 2020,32（5）:409⁃416. doi: 10.5021/ad.2020.32.5.409.
［14］	Zhou X, Ma Y, Liu F, et al. Melanocyte chitosan/gelatin composite fabrication with human outer root sheath⁃derived cells to produce pigment［J］. Sci Rep, 2019,9（1）:5198. doi: 10.1038/s41598⁃019⁃41611⁃5.
［15］	Liu J, Liu S, Guo M, et al. Clinical validation and study of stem cell transplantation in treatment of vitiligo［J］. Arch Dermatol Res, 2023,315（10）:2983⁃2984. doi: 10.1007/s00403⁃023⁃02692⁃5.
［16］	Wilamowska⁃Kokoszko D, Łukasik K, Szepietowski JC, et al. Assessment of stem cell factor expression and its c⁃KIT receptor in patients with vitiligo［J］. Postepy Dermatol Alergol, 2022,39（4）:762⁃767. doi: 10.5114/ada.2021.110266.
［17］	Touni AA, Shivde RS, Echuri H, et al. Melanocyte⁃keratinocyte cross⁃talk in vitiligo［J］. Front Med （Lausanne）, 2023,10:1176781. doi: 10.3389/fmed.2023.1176781.
［18］	Suo D, Zeng S, Zhang J, et al. PM2.5 induces apoptosis, oxidative stress injury and melanin metabolic disorder in human melanocytes［J］. Exp Ther Med, 2020,19（5）:3227⁃3238. doi: 10. 3892/etm.2020.8590.
［19］	Hua C, Liang Q, Chen S, et al. Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis⁃like mouse model［J］. Stem Cell Res Ther, 2023,14（1）:147. doi: 10.1186/s13287⁃023⁃03365⁃w.
［20］	Ko E, Yoon T, Lee Y, et al. ADSC secretome constrains NK cell activity by attenuating IL⁃2⁃mediated JAK⁃STAT and AKT signaling pathway via upregulation of CIS and DUSP4［J］. Stem Cell Res Ther, 2023,14（1）:329. doi: 10.1186/s13287⁃023⁃03516⁃z.
［21］	Gao J, Zhang G, Xu K, et al. Bone marrow mesenchymal stem cells improve bone erosion in collagen⁃induced arthritis by inhibiting osteoclasia⁃related factors and differentiating into chondrocytes［J］. Stem Cell Res Ther, 2020,11（1）:171. doi: 10. 1186/s13287⁃020⁃01684⁃w.
［22］	Nguyen Huu T, Park J, Zhang Y, et al. Redox regulation of PTEN by peroxiredoxins［J］. Antioxidants （Basel）, 2021,10（2）:302. doi: 10.3390/antiox10020302.
［23］	Zhu L, Lin X, Zhi L, et al. Mesenchymal stem cells promote human melanocytes proliferation and resistance to apoptosis through PTEN pathway in vitiligo［J］. Stem Cell Res Ther, 2020,11（1）:26. doi: 10.1186/s13287⁃019⁃1543⁃z.
［24］	Chang WL, Ko CH. The role of oxidative stress in vitiligo: an update on its pathogenesis and therapeutic implications［J］. Cells, 2023,12（6）:936. doi: 10.3390/cells12060936.
［25］	Bian Y, Yu H, Jin M, et al. Repigmentation by combined narrow‑band ultraviolet B/adipose‑derived stem cell transplantation in the mouse model: role of Nrf2/HO‑1‑mediated Ca2+ homeostasis［J］. Mol Med Rep, 2022,25（1）:6. doi: 10.3892/mmr.2021.12522.
［26］	Dong D, Chen S, Feng C, et al. NB⁃UVB induces melanocytic differentiation of human hair follicle neural crest stem cells［J］. Ann Dermatol, 2020,32（4）:289⁃297. doi: 10.5021/ad.2020.32. 4.289.
［27］	An L, Kim D, Donahue LR, et al. Sexual dimorphism in melanocyte stem cell behavior reveals combinational therapeutic strategies for cutaneous repigmentation［J］. Nat Commun, 2024,15（1）:796. doi: 10.1038/s41467⁃024⁃45034⁃3.
［28］	Kumari U, Pervaiz N, Kaur H, et al. Lenalidomide augments differentiation of cultured hair follicle derived melanocyte stem cells into functional melanocytes［J］. Dermatol Pract Concept, 2023,13（2）:e2023077. doi: 10.5826/dpc.1302a77.
［29］	Vashisht KR, Arava SK, Tembhre MK, et al. A randomized pilot study to compare hair follicle cell suspensions prepared using trypsin alone versus trypsin in combination with collagenase type I for transplantation in vitiligo［J］. Clin Exp Dermatol, 2020,45（2）:172⁃179. doi: 10.1111/ced.14061.
［30］	Liu J, Chen Q. Clinical effect of stem cell transplantation combined with 308⁃nm excimer laser therapy for 56 cases of vitiligo［J］. J Cosmet Dermatol, 2023,22（12）:3276⁃3281. doi: 10.1111/jocd.15833.
［31］	Gabr H, Elkheir WA. Combined local melanocytes and systemic mesenchymal stem cell injection in vitiligo treatment［J/OL］. Cytotherapy, 2015,17（6 Suppl）:S13. doi: 10.1016/j.jcyt.2015. 03.328. https://www.sciencedirect.com/science/article/pii/S146532 4915004120.

[1]	Luo Li, Zhang Bona, Wu Wei, Tang Wenjing, Li Yuehua, Liu Xiaoli, Ma Yanan, Li Cuicui, Qi Mengyan, Sun Ni, Shi Qiong. Efficacy and safety of 308-nm excimer laser and 308-nm excimer lamp in the treatment of 194 children with vitiligo: a retrospective study [J]. Chinese Journal of Dermatology, 2024, 57(8): 721-727.
[2]	Chen Jiaxi, Yi Xiuli, Li Chunying, Li Shuli. Study on the protective effect of folic acid against oxidative stress-induced damage to melanocytes in vitro [J]. Chinese Journal of Dermatology, 2024, 57(6): 547-552.
[3]	Zhang Dimin, Cao Cheng, Zhou Miaoni, Sheng Anqi, Lin Fuquan, Xu Ai′e. Analysis of disease control rate and its influencing factors in patients with progressive non-segmental vitiligo after combined treatment with compound betamethasone injection [J]. Chinese Journal of Dermatology, 2024, 57(4): 350-354.
[4]	Zhou Tiantian, Wu Xuege, Yang Huan, Fang Xiao, Jiang Jinqiu, Chen Jingsi, Luo Xiaoyan, Wang Hua. Analysis of the etiology and factors associated with the severity of chronic spontaneous urticaria in children [J]. Chinese Journal of Dermatology, 2024, 57(4): 324-330.
[5]	Gao Jinping, Zhang Xuejun, . Clinical application of baricitinib in dermatology [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230528-e20230528.
[6]	Xu Zhuohong, Zhou Xuyue, Hu Yu, Gu Heng. Role of mast cells in the pathogenesis of chronic spontaneous urticaria and advances in mast cell-targeted therapies [J]. Chinese Journal of Dermatology, 2024, 0(3): 20240291-e20240291.
[7]	Yao Manxue, Zhou Naihui. Stevens-Johnson syndrome/toxic epidermal necrolysis associated with programmed death-1/programmed death-ligand 1 inhibitors [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220644-e20220644.
[8]	Ma Tongchuan, Deng Tingyue, Xiao Fengli. Associations between smoking and atopic dermatitis [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220793-e20220793.
[9]	Dai Yeqin, Song Xiuzu. Application of hair follicle transplantation and follicular cell suspension transplantation in the treatment of vitiligo [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230274-e0230274.
[10]	Liu Lyuye, Zhang Junling. Ferroptosis in common skin diseases [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220783-e20220783.
[11]	Sun Weiwei, Chen Jianru, Li Shuli, Gao Tianwen, Li Chunying . Analysis of depression-like behavioral performances of mouse models of vitiligo [J]. Chinese Journal of Dermatology, 2024, 57(2): 147-154.
[12]	Pigmentary Disorder Group, Combination of Traditional and Western Medicine Dermatology, Research Center for Vitiligo, Chinese Society of Dermatology, Committee on Pigmentation Disorders, China Dermatologist Association . Consensus on the diagnosis and treatment of vitiligo （2024 version） [J]. Chinese Journal of Dermatology, 2024, 57(12): 1065-1070.
[13]	Yang Siyan, Ma Lin, Zhang Bin. Application of crisaborole ointment in dermatology [J]. Chinese Journal of Dermatology, 2024, 57(10): 962-966.
[14]	Wang Tao, Wu Yi, Jin Hong, Dai Yeqin, Peng Jianzhong, Xu Ai′e, Song Xiuzu. Efficacy of electrolysis of depigmented hair combined with hair follicle transplantation in the treatment of 25 cases of vitiligo-associated leukotrichia: a retrospective analysis [J]. Chinese Journal of Dermatology, 2024, 57(1): 46-49.
[15]	Guliziba·Tuersun, Qu Yuanyuan. New advances in the treatment of vitiligo with JAK-STAT inhibitors [J]. Chinese Journal of Dermatology, 2024, 57(1): 71-75.

Stem cell therapy for vitiligo: advances in basic and clinical research

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［31］

Related Articles 15

Metrics

Comments

Recommended 10